Peter Johannes Holst

Peter Johannes Holst

Guest Researcher

Member of:

  • EXPVACC/LEV team

ORCID: 0000-0002-1279-304X

Publication year:
All
1 - 4 out of 4Page size: 25
  1. 2021
  2. Published

    Comment on: Endogenous retroviruses expressed in human tumours cannot be used as targets for anti-tumour vaccines

    Bermejo, A. V., Nielsen, K. N. & Holst, Peter Johannes, 2021, In: Translational Oncology. 14, 5, 3 p., 101040.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  3. Published

    Design and immunological validation of Macaca fascicularis Papillomavirus Type 3 based vaccine candidates in outbred mice: Basis for future testing of a therapeutic papillomavirus vaccine in NHPs

    Neckermann, P., Boilesen, D. R., Willert, T., Pertl, C., Schrödel, S., Thirion, C., Asbach, B., Holst, Peter Johannes & Wagner, R., 2021, In: Frontiers in Immunology. 12, 761214.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Novel antigenic targets of HPV therapeutic vaccines

    Boilesen, D. R., Nielsen, K. N. & Holst, Peter Johannes, 2021, In: Vaccines. 9, 11, 22 p., 1262.

    Research output: Contribution to journal › Review › Research › peer-review

  5. Published

    The C-terminal peptide of CCL21 drastically augments CCL21 activity through the dendritic cell lymph node homing receptor CCR7 by interaction with the receptor N-terminus

    Jørgensen, Astrid Sissel, Brandum, E. P., Mikkelsen, J. M., Orfin, K. A., Boilesen, D. R., Egerod, Kristoffer Lihme, Moussouras, N. A., Vilhardt, Frederik, Kalinski, P., Basse, P., Chen, Yen-Hsi, Yang, Zhang, Dwinell, M. B., Volkman, B. F., Veldkamp, C. T., Holst, Peter Johannes, Lahl, K., Goth, C. K., Rosenkilde, Mette & Hjortø, Gertrud Malene, 2021, In: Cellular and Molecular Life Sciences. 78, p. 6963-6978 16 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 7853